Paper22326293
Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.
Tian T and 6 others. Eur J Cancer, 2012. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers. Papers, record 22326293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22326293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Hodgkin Disease | Major topic |
| Lung Neoplasms | Major topic |
| Mitochondria | Major topic |
| Neoplasm Proteins | Major topic |
| Adenocarcinoma of Lung | |
| Apoptosis | |
| Cell Growth Processes | |
| Cell Line, Tumor | |
| Gene Expression Regulation | |
| Gene Knockdown Techniques | |
| Humans | |
| Immunohistochemistry | |
| Transcription, Genetic |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41969495 | Targeting LRPPRC lactylation disrupts metabolic-immune crosstalk and restores antitumor immunity in hepatocellular carcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41969495 | PubMed |
| 40775462 | Leucyl-tRNA synthetase promotes malignant progression in diffuse large B-cell lymphoma by regulating glycolysis via the LRPPRC/HIF-1α/HK2 axis. | Hum Cell | 2025 | https://conductscience.org/library/papers/40775462 | PubMed |
| 40607235 | Disruption of Lrpprc affects B cell development and proliferation in a mouse model of Leigh Syndrome French Canadian type. | J Rare Dis (Berlin) | 2025 | https://conductscience.org/library/papers/40607235 | PubMed |
| 40587247 | The Biological Role of LRPPRC in Human Cancers. | Cancer Control | 2025 | https://conductscience.org/library/papers/40587247 | PubMed |
| 39215663 | The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/39215663 | PubMed |
| 39022790 | Prognostic significance of LRPPRC and its association with immune infiltration in liver hepatocellular carcinoma. | Am J Clin Exp Immunol | 2024 | https://conductscience.org/library/papers/39022790 | PubMed |
| 38706791 | Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC). | Front Genet | 2024 | https://conductscience.org/library/papers/38706791 | PubMed |
| 38397966 | Transcriptome-Wide N6-Methyladenosine Alternations in Pulmonary Arteries of Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats and Novel Therapeutic Targets. | Biomedicines | 2024 | https://conductscience.org/library/papers/38397966 | PubMed |
| 37789316 | LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37789316 | PubMed |
| 37700277 | GREM1, LRPPRC and SLC39A4 as potential biomarkers of intervertebral disc degeneration: a bioinformatics analysis based on multiple microarray and single-cell sequencing data. | BMC Musculoskelet Disord | 2023 | https://conductscience.org/library/papers/37700277 | PubMed |
| 37534256 | A novel machine learning-based programmed cell death-related clinical diagnostic and prognostic model associated with immune infiltration in endometrial cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/37534256 | PubMed |
| 37452037 | The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer. | Nat Commun | 2023 | https://conductscience.org/library/papers/37452037 | PubMed |
| 37284034 | The Role of RNA Methylation Modification Related Genes in Prognosis and Immunotherapy of Colorectal Cancer. | Int J Gen Med | 2023 | https://conductscience.org/library/papers/37284034 | PubMed |
| 37034224 | DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma. | Am J Cancer Res | 2023 | https://conductscience.org/library/papers/37034224 | PubMed |
| 35242578 | Expression signature of the Leigh syndrome French-Canadian type. | Mol Genet Metab Rep | 2022 | https://conductscience.org/library/papers/35242578 | PubMed |
| 35237297 | Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene Via Maintaining Mitochondrial Function in Pancreatic Cancer. | Front Genet | 2021 | https://conductscience.org/library/papers/35237297 | PubMed |
| 34745261 | m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment. | J Oncol | 2021 | https://conductscience.org/library/papers/34745261 | PubMed |
| 34650549 | Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m6A Regulators in Early-Stage Lung Adenocarcinoma. | Front Immunol | 2021 | https://conductscience.org/library/papers/34650549 | PubMed |
| 34589577 | LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/34589577 | PubMed |
| 33362863 | Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer. | Front Genet | 2020 | https://conductscience.org/library/papers/33362863 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| LRPPRC | 10128 | PubTator's text mining | https://conductscience.org/library/genes/10128 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22326293
GET https://conductscience.org/api/papers/v1/22326293/cited_by?page=2